Perinatal HIV Infection
Showing 1 - 25 of >10,000
Immune Correlates of Cardiac Structure and Function
Completed
- Perinatal HIV Infection
- +2 more
- Cardiac MRI
-
Durham, North CarolinaDuke University Health System
Oct 24, 2022
Sexual Needs of Adolescents Living With HIV Since Childhood
Not yet recruiting
- Hiv
- Perinatal HIV Infection
- Interview
-
Paris, FranceMaison de Solenn
Jan 24, 2022
Perinatal Depression, HIV-1-infection Trial in Lusaka (Sertraline, Interpersonal therapy)
Completed
- Perinatal Depression
- HIV-1-infection
- Sertraline
- Interpersonal therapy
-
Lusaka, Zambia
- +1 more
Oct 12, 2021
Covid19 Trial in Klerksdorp (Triazavirin (Riamilovir), Placebo)
Terminated
- Covid19
- Triazavirin (Riamilovir)
- Placebo
-
Klerksdorp, North West Province, South AfricaThe Perinatal HIV Research Unit - Matlosana
Jul 29, 2022
HIV Birth Testing In Maternity Settings In Zimbabwe
Completed
- HIV/AIDS
- +3 more
- Point of care early infant diagnosis (POC EID)
-
Beitbridge, Zimbabwe
- +9 more
Aug 17, 2021
COVID-19, Influenza and RSV Burden, Transmission Dynamics and
Active, not recruiting
- SARS-CoV-2 Infection
- +2 more
-
Agincourt, Mpumalanga, South Africa
- +1 more
Mar 11, 2022
HIV-1 Trial in Worldwide (Ad26.Mos4.HIV, Clade C gp140, Placebo)
Completed
- HIV-1
- Ad26.Mos4.HIV
- +2 more
-
Lilongwe, Malawi
- +22 more
Apr 12, 2022
HIV Infection Trial in South Africa (ALVAC-HIV, Bivalent Subtype C gp120/MF59®, ALVAC-HIV (vCP2438) Placebo)
Completed
- HIV Infection
- ALVAC-HIV
- +3 more
-
Durban, KwaZulu-Natal, South Africa
- +4 more
Nov 3, 2021
HIV-1 Infection Trial in Worldwide (DOR/ISL)
Active, not recruiting
- HIV-1 Infection
-
Washington, District of Columbia
- +16 more
Oct 13, 2022
COHIVE: Coronavirus Outcomes in HIV Evaluation in Resource
Completed
- HIV-infection/Aids
- Coronavirus Infection
-
Buenos Aires, Ciudad De Buenos Aires, Argentina
- +14 more
Mar 16, 2022
HIV Preexposure Prophylaxis Trial in Worldwide (ISL, FTC/TDF, FTC/TAF)
Active, not recruiting
- HIV Preexposure Prophylaxis
- ISL
- +5 more
-
Birmingham, Alabama
- +24 more
Aug 15, 2022
HIV Trial in Worldwide (NRTIs, Dolutegravir, Darunavir)
Active, not recruiting
- HIV Infections
- NRTIs
- +3 more
-
Buenos Aires, Ciudad De Buenos Aires, Argentina
- +27 more
Nov 27, 2022
Point of Care Birth Testing in Eswatini
Completed
- HIV Infections
- +5 more
- Point-of-care birth test
-
Mbabane, SwazilandMbabane Government Hospital, Hlathikhulu Hospital, and Good Shep
Feb 3, 2021
Perinatal Transmission of MDR Bacteria
Recruiting
- E. Coli Infection
- Multi-antibiotic Resistance
-
Chicago, IllinoisPrentice Women's Hospital
Nov 20, 2023
HIV/AIDS, Infant Morbidity, Pediatric HIV Infection Trial in Nairobi, Harare (Point of Care Early Infant Diagnosis, Standard of
Completed
- HIV/AIDS
- +3 more
- Point of Care Early Infant Diagnosis
- Standard of Care Early Infant Diagnosis
-
Nairobi, Kenya
- +1 more
Feb 3, 2021
Maternal-fetal Infection Transmission Trial in France (darunavir monotherapy)
Completed
- Maternal-fetal Infection Transmission
- darunavir monotherapy
-
Argenteuil, France
- +22 more
Aug 5, 2021
Reservoir in Individuals Controlling HIV Infection
Not yet recruiting
- Hiv
- (no location specified)
Aug 23, 2023
Alcohol Use Disorder, Human Immunodeficiency Virus Trial in Chicago (10 day prebiotic consumption)
Not yet recruiting
- Alcohol Use Disorder
- Human Immunodeficiency Virus
- 10 day prebiotic consumption
-
Chicago, IllinoisAli Keshavarzian
Nov 14, 2023
Participants 18 Years of Age or Older - Lite
Recruiting
- HIV/AIDS
-
Los Angeles, California
- +8 more
Aug 26, 2022
Seroprevalence of Monkeypox Infection Among People Living With
Not yet recruiting
- Monkey Pox
- HIV Infections
- Questionnaire
- (no location specified)
Jun 20, 2023
HIV-1-infection Trial (Low-dose STP0404 (Pirmitegravir), Medium-dose STP0404 (Pirmitegravir), High-dose STP0404 (Pirmitegravir))
Not yet recruiting
- HIV-1-infection
- Low-dose STP0404 (Pirmitegravir)
- +3 more
- (no location specified)
May 16, 2023
HIV, HIV Pre-exposure Prophylaxis Trial (MK-8527, Placebo to MK-8527)
Not yet recruiting
- HIV
- HIV Pre-exposure Prophylaxis
- MK-8527
- Placebo to MK-8527
- (no location specified)
Sep 21, 2023
Tuberculosis, Pulmonary, Tuberculosis, MDR, Tuberculosis Infection Trial in Tbilisi, Soweto, Klerksdorp (Control group, ASA
Recruiting
- Tuberculosis, Pulmonary
- +2 more
- Control group
- +3 more
-
Tbilisi, Georgia
- +2 more
Apr 6, 2021